Already on the 18th in the USA, 6 million doses of Modena vaccine began to be supplied.

The United States, which has begun to inoculate the public with the new vaccine against coronavirus infection (Corona 19), is accelerating its spread.

According to the CNBC broadcast on the 15th (local time), the US government plans to inoculate the public with the vaccine being developed by its pharmaceutical company Modena as soon as it receives approval for emergency use from the Food and Drug Administration. US Drugs (FDA).

Broadcasting predicted that 6 million doses of modder or vaccines (one dose for one dose) are expected to be approved for emergency use by the FDA beginning on the 18th and to begin shipping.

The Vaccines and Biologicals Advisory Committee (VRBPAC), an advisory body to the FDA, is scheduled to begin reviewing the Modena vaccines on the 17th.

The US health community expects the FDA to approve the emergency use of modder or vaccine from day 18.

Previously, the FDA approved the COVID-19 vaccine developed by Pfizer in the United States and Bioentech in Germany on the 11th, the day after receiving an emergency use recommendation from the Advisory Committee.

Once the modder or vaccine is approved for emergency use, McKesson Pharmaceutical Distributor will ship the vaccine to 3,285 distribution centers in the United States.

Army Gen. Gustav Ferna, director of operations (COO) for the U.S. government’s Corona 19 vaccine development program, Ultra High Speed ​​Operations, said UPS and FedEx will move these vaccines to the inoculum.

The initial quantity of modders or vaccines insured by the United States government is approximately 6 million doses. This is twice the size of the 2.9 million doses of Pfizer’s primary vaccine supply.

Meanwhile, the US government is adjusting the rate of vaccination while stockpiling safety stocks so that the second vaccination of the Pfizer vaccine, which has been delivered, can continue without interruption.

The Pfizer vaccine is given in two doses at intervals. Currently, the US government reserves 500,000 doses of the Pfizer-Bioentech vaccine.

“Vaccines on the shelf are useless,” said COO Funna. “If the vaccine production and distribution process is improved, the safety inventory will be significantly reduced.”

Monsef Slawi, executive director of high-speed operations, announced today that by the end of this year, 20 million people will be vaccinated with either the Pfizer-Bioentech vaccine or the Modena vaccine.

[연합뉴스]

Copyright ⓒ Yonhap News. Unauthorized reproduction and redistribution prohibited